Occudo Quantitative Strategies LP Gilead Sciences, Inc. Transaction History

Occudo Quantitative Strategies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $6.03 Million - $6.79 Million	-104,463 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $6.05 Million - $7.58 Million	104,463 New	104,463 $6.21 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $417,600 - $476,481	-6,960 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $394,284 - $449,268	6,960 New	6,960 $405,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.